tiprankstipranks
Advertisement
Advertisement
AUTL Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsAUTL Upcoming Earnings Report: What to Expect?
29d ago
Autolus Therapeutics: Buy Rating Reiterated as Aucatzyl Outperforms and Non-Dilutive Financing Extends Runway; $10 Price Target Maintained
Premium
Ratings
Autolus Therapeutics: Buy Rating Reiterated as Aucatzyl Outperforms and Non-Dilutive Financing Extends Runway; $10 Price Target Maintained
1M ago
Autolus Raises AUCATZYL Outlook, Secures New Credit Facility
Premium
Company Announcements
Autolus Raises AUCATZYL Outlook, Secures New Credit Facility
1M ago
Autolus Therapeutics Signals Turning Point in Earnings
PremiumCompany AnnouncementsAutolus Therapeutics Signals Turning Point in Earnings
4M ago
Autolus Therapeutics: Buy Rating Reiterated as Aucatzyl Momentum Builds and Pipeline Advances; $10 Price Target Maintained
Premium
Ratings
Autolus Therapeutics: Buy Rating Reiterated as Aucatzyl Momentum Builds and Pipeline Advances; $10 Price Target Maintained
4M ago
Matt Phipps Reiterates Buy on Autolus as Aucatzyl’s Profitability Inflects and Blockbuster Potential Builds on Expanding Indications
Premium
Ratings
Matt Phipps Reiterates Buy on Autolus as Aucatzyl’s Profitability Inflects and Blockbuster Potential Builds on Expanding Indications
4M ago
Autolus Therapeutics (AUTL) Q1 Earnings Cheat Sheet
PremiumPre-EarningsAutolus Therapeutics (AUTL) Q1 Earnings Cheat Sheet
4M ago
Analyst Maintains Buy on Autolus, Reiterates $9 Price Target on Restructuring Savings and Clinical Catalysts
Premium
Ratings
Analyst Maintains Buy on Autolus, Reiterates $9 Price Target on Restructuring Savings and Clinical Catalysts
4M ago
Autolus Therapeutics Announces Workforce Reduction and Cost Restructuring
Premium
Company Announcements
Autolus Therapeutics Announces Workforce Reduction and Cost Restructuring
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100